Drug shortage
Amphetamine Aspartate Monohydrate · Granules Pharmaceuticals Inc.
FDA drug shortage · Current · updated Mar 18, 2025
Key facts
| Generic name | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet |
|---|---|
| Proprietary name | Dextroamp Saccharate, Amp Aspartate, Dextroamp Sulfate And Amp Sulfate |
| Company | Granules Pharmaceuticals Inc. |
| Presentation | Dextroamp Saccharate, Amp Aspartate, Dextroamp Sulfate And Amp Sulfate, Tablet, 3.125 mg; 3.125 mg; 3.125 mg; 3.125 mg (NDC 70010-114-01) |
| Dosage form | Tablet |
| Strength | 3.125 mg |
| Status | Current |
| Reason for shortage | Shortage of an active ingredient |
| Therapeutic category | Psychiatry |
| Package NDCs | 70010-114-01 |
| First posted | Oct 12, 2022 |
| Last updated | Mar 18, 2025 |
At a glance
- 1–9 Package NDCs affected
- 100–999 FDA shortage records for this drug
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug shortages
The FDA Drug Shortages Database lists current and resolved shortages of drugs, with presentations, affected NDCs and reasons reported by manufacturers.
Source: U.S. Food and Drug Administration (FDA), Drug Shortages Database · Source date: